Published in Microbes Infect on May 01, 2004
T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood (2005) 2.95
T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med (2006) 2.38
T-bet protects against exacerbation of schistosome egg-induced immunopathology by regulating Th17-mediated inflammation. Eur J Immunol (2009) 1.10
T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance. Proc Natl Acad Sci U S A (2013) 1.08
Upregulation of T-bet expression in peripheral blood mononuclear cells during Vogt-Koyanagi-Harada disease. Br J Ophthalmol (2005) 0.89
TLR7, IFNγ, and T-bet: their roles in the development of ABCs in female-biased autoimmunity. Cell Immunol (2014) 0.80
T-bet overexpression regulates AHR-mediated Th-17 differentiation through an IFNγ-independent pathway. Clin Exp Immunol (2016) 0.75
Resistin, an adipokine with potent proinflammatory properties. J Immunol (2005) 3.63
The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. Cell Host Microbe (2007) 2.27
Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukoc Biol (2004) 2.17
High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum (2003) 1.93
Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus. J Bacteriol (2006) 1.86
Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol (2004) 1.80
Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum (2003) 1.65
Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging (2002) 1.56
Complement deficiency ameliorates collagen-induced arthritis in mice. J Immunol (2002) 1.51
Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis (2008) 1.48
GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer. J Clin Invest (2007) 1.47
Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther (2005) 1.43
On the role of Staphylococcus aureus sortase and sortase-catalyzed surface protein anchoring in murine septic arthritis. J Infect Dis (2002) 1.39
Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS One (2006) 1.38
Characterization of IsaA and SceD, two putative lytic transglycosylases of Staphylococcus aureus. J Bacteriol (2007) 1.34
Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis. Arthritis Res Ther (2009) 1.26
Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1. Arthritis Rheum (2006) 1.24
The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS One (2009) 1.19
Identification and characterization of sigma, a novel component of the Staphylococcus aureus stress and virulence responses. PLoS One (2008) 1.19
Ethanol prevents development of destructive arthritis. Proc Natl Acad Sci U S A (2006) 1.18
Mice chronically fed high-fat diet have increased mortality and disturbed immune response in sepsis. PLoS One (2009) 1.18
Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. PLoS One (2008) 1.14
Reactive oxygen species produced by the NADPH oxidase 2 complex in monocytes protect mice from bacterial infections. J Immunol (2012) 1.13
Critical role of signaling through IL-1 receptor for development of arthritis and sepsis during Staphylococcus aureus infection. J Immunol (2002) 1.09
Staphylococcus aureus: Staphylokinase. Int J Biochem Cell Biol (2005) 1.08
Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis. Arthritis Res Ther (2008) 1.08
Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus. J Rheumatol (2008) 1.05
Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Arthritis Res Ther (2005) 1.05
Inactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureus. Infect Immun (2007) 1.04
Tissue factor as a proinflammatory agent. Arthritis Res (2002) 1.04
Immune evasion by Staphylococcus aureus conferred by iron-regulated surface determinant protein IsdH. Microbiology (2009) 1.02
Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation. Arthritis Res Ther (2005) 1.02
Phenotypic and functional characterization of human CD25+ B cells. Immunology (2006) 1.02
Arthritogenic properties of double-stranded (viral) RNA. J Immunol (2004) 1.01
Identification of an intracellular M17 family leucine aminopeptidase that is required for virulence in Staphylococcus aureus. Microbes Infect (2012) 0.99
Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. J Med Microbiol (2003) 0.99
In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes. Infect Immun (2002) 0.97
Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res Ther (2003) 0.97
Resistin is stored in neutrophil granules being released upon challenge with inflammatory stimuli. Biochim Biophys Acta (2009) 0.95
Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice. Arthritis Res Ther (2009) 0.93
Intra-articular fms-like tyrosine kinase 3 ligand expression is a driving force in induction and progression of arthritis. PLoS One (2008) 0.92
The impact of Fcgamma receptors on Staphylococcus aureus infection. Microb Pathog (2002) 0.92
Smoking and nicotine exposure delay development of collagen-induced arthritis in mice. Arthritis Res Ther (2009) 0.91
Survivin is an essential mediator of arthritis interacting with urokinase signalling. J Cell Mol Med (2009) 0.91
Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties. J Rheumatol (2007) 0.91
Phytoestrogen genistein as an anti-staphylococcal agent. Microbes Infect (2004) 0.90
Increased expression of proto-oncogene survivin predicts Joint destruction and persistent disease activity in early rheumatoid arthritis. Ann Med (2010) 0.89
Cerebral inflammation and degeneration in systemic lupus erythematosus. Curr Opin Rheumatol (2004) 0.88
The peptide AF-16 abolishes sickness and death at experimental encephalitis by reducing increase of intracranial pressure. Brain Res (2008) 0.86
Intraarticular release and accumulation of defensins and bactericidal/permeability-increasing protein in patients with rheumatoid arthritis. J Rheumatol (2003) 0.86
Extracellular survivin up-regulates adhesion molecules on the surface of leukocytes changing their reactivity pattern. J Leukoc Biol (2007) 0.86
Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis. Arthritis Rheum (2009) 0.86
Uric acid, a nucleic acid degradation product, down-regulates dsRNA-triggered arthritis. J Leukoc Biol (2005) 0.85
Role of fibrinogen-binding adhesin expression in septic arthritis and septicemia caused by Streptococcus agalactiae. J Infect Dis (2005) 0.85
Anti-staphylococcal activities of lysostaphin and LytM catalytic domain. BMC Microbiol (2012) 0.85
Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis. Arthritis Res Ther (2002) 0.84
In vivo sortase A and clumping factor A mRNA expression during Staphylococcus aureus infection. Microb Pathog (2007) 0.84
Impact of staphylococcal protease expression on the outcome of infectious arthritis. Microbes Infect (2004) 0.84
Arthritogenic dsRNA is present in synovial fluid from rheumatoid arthritis patients with an erosive disease course. Eur J Immunol (2008) 0.84
Salivary resistin reflects local inflammation in Sjögren's syndrome. J Rheumatol (2008) 0.83
Human alpha -defensins neutralize fibrinolytic activity exerted by staphylokinase. Thromb Haemost (2004) 0.83
The presence of local and circulating autoreactive B cells in patients with advanced periodontitis. J Clin Periodontol (2002) 0.83
mgrA regulates staphylococcal virulence important for induction and progression of septic arthritis and sepsis. Microbes Infect (2008) 0.82
Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus. Arthritis Res Ther (2004) 0.82
Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis. Scand J Infect Dis (2010) 0.82
Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement. Arthritis Res Ther (2004) 0.82
Inflammatogenic properties of bacterial DNA following cutaneous exposure. J Invest Dermatol (2003) 0.82
Requirement of type I interferon signaling for arthritis triggered by double-stranded RNA. Arthritis Rheum (2006) 0.82
Rapid systemic bone resorption during the course of Staphylococcus aureus-induced arthritis. J Infect Dis (2006) 0.81
Formylated peptides are important virulence factors in Staphylococcus aureus arthritis in mice. J Infect Dis (2011) 0.81
Single-stranded polyinosinic acid oligonucleotides trigger leukocyte production of proteins belonging to fibrinolytic and coagulation cascades. J Leukoc Biol (2008) 0.81
Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women. J Rheumatol (2004) 0.81
Current status of pathogenetic mechanisms in staphylococcal arthritis. FEMS Microbiol Lett (2002) 0.81
Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis. Microbes Infect (2006) 0.81
Staphylokinase reduces plasmin formation by endogenous plasminogen activators. Eur J Haematol (2008) 0.81
The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs. Inflammation (2004) 0.80
Urokinase-type plasminogen activator, an endogenous antibiotic. J Infect Dis (2005) 0.80
Mucosal tolerance to a bacterial superantigen indicates a novel pathway to prevent toxic shock. Infect Immun (2002) 0.80
Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis. J Orthop Res (2007) 0.80
Inhibition of septic arthritis by local administration of taurine chloramine, a product of activated neutrophils. J Rheumatol (2005) 0.80
The impact of a new immunomodulator oxo-quinoline-3-carboxamide on the progression of experimental lupus. Int Immunopharmacol (2004) 0.79
RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis. Bone (2009) 0.79
Induction of arthritis by high mobility group box chromosomal protein 1 is independent of tumour necrosis factor signalling. Arthritis Res Ther (2008) 0.79
Identification of conserved antigens from staphylococcal and streptococcal pathogens. J Med Microbiol (2012) 0.78
Immunostimulatory DNA induces degranulation and NADPH-oxidase activation in human neutrophils while concomitantly inhibiting chemotaxis and phagocytosis. Eur J Immunol (2002) 0.78
Expression and functional properties of antibodies to tissue inhibitors of metalloproteinases (TIMPs) in rheumatoid arthritis. Arthritis Res Ther (2005) 0.78
The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial. Rheumatology (Oxford) (2009) 0.77
The role of B cell CD22 expression in Staphylococcus aureus arthritis and sepsis. Microbes Infect (2004) 0.77
Microbial superantigens as virulence factors and ways to counteract their actions. Scand J Infect Dis (2003) 0.77
Staphylococcus aureus infection triggers production of neutralizing, V8 protease-specific antibodies. FEMS Immunol Med Microbiol (2008) 0.76
Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum (2009) 0.76
Synergistic action of immunostimulatory DNA and fcgamma receptor IIB-crosslinking on B-cell phenotype and function. Immunobiology (2005) 0.75
Polarization of cytokine responses in B- and T-lymphocytes during Staphylococcus aureus infection. Microb Pathog (2003) 0.75
Anti-proliferative effects of phosphodiester oligodeoxynucleotides. Immunobiology (2004) 0.75
Carbohydrates and biology of staphylococcal infections. Adv Exp Med Biol (2005) 0.75
Impact of site-specific nucleobase deletions on the arthritogenicity of DNA. Inflammation (2004) 0.75